Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis

Young Lan Kwon, Eun Soo Kim, Kyung In Lee, Yong Jin Kim, Chang Wook Park, Yun Jung Kim, Hye Jin Seo, Kwang Bum Cho, Kyung Sik Park, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Background Little is known about the feasibility of endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for patients with chronic renal failure (CRF) or liver cirrhosis (LC). This study aimed to assess the safety, efficacy, and clinical outcomes of EMR or ESD in patients with CRF or LC compared to those in patients without. Methods Between February 2003 and November 2009, a total of 1016 gastric neoplastic lesions in 928 patients were treated by using EMR or ESD. Among them, 18 patients had LC and 17 patients had CRF. Their medical records were reviewed retrospectively. En bloc resection rate, histological complete resection rate, operation time, and complications were compared between patients with CRF or LC and those without (control group). Results Baseline characteristics were not significantly different between the CRF, LC, and control groups except for a high rate of comorbidities in the CRF group and prolonged prothrombin time in the LC group. Operation time and therapeutic outcomes such as en bloc and complete resection rates did not differ significantly between the groups. Immediate bleeding tended to occur more frequently in the CRF + LC group than in controls (47.5 vs. 33.9%, p = 0.077). There was no significant difference in the incidence of perforation between the CRF, LC, and control groups. The hospital stay was longer in the CRF + LC group than in the control group (6.4 ± 3.53 vs. 4.9 ± 3.15 days, p = 0.012). Conclusions EMR and ESD for the treatment of early gastric neoplasia may be equally effective and tolerable in the CRF or the LC group compared to the control group, although patients with CRF or LC might need the longer admission period than the control group.

Original languageEnglish
Pages (from-to)1994-1999
Number of pages6
JournalSurgical Endoscopy and Other Interventional Techniques
Volume25
Issue number6
DOIs
StatePublished - Jun 2011

Keywords

  • Chronic renal failure
  • Endoscopy
  • Liver cirrhosis

Fingerprint

Dive into the research topics of 'Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis'. Together they form a unique fingerprint.

Cite this